Eurobio Scientific Team

Our History

2025

         

  • Acquisition of Quimark and life science business unit in Italy
2025

2024

Endopredict®/Prolaris®

  • Acquisition of Alpha Biotech (GenDx distributor)
  • SPA EndoPredict
2024

2023

Acquisition of D.I.D, a supplier of in-vitro tests

  • Diagnostic International Distribution SpA (DID) is an Italian distributor of medical diagnostic products based in Milan. With more than 70 years of service to the microbiology laboratory, it operates in both clinical and industrial markets, offering high quality solutions. Throughout its long history and thanks to its reputation for excellence, DID has always supported the solid growth of the Italian medical and industrial markets.

    DID adheres to the highest standards (ISO9001) in all its operations and focuses on the breadth and depth of its product ranges to serve its customers, supported by talented staff (26 employees) and open and transparent business practices.

    DID is part of the Eurobio Scientific Group since July 2023.
2023

10.2022

Acquisition of GenDx, a provider of molecular diagnostic solutions

  • Specialized in molecular transplant diagnostics, GenDx develops and offers a comprehensive line of reagents and services, analysis software, and education.

    GenDx is a pioneer in the area of Sequencing-Based Typing (SBT) for transplantation, offering high resolution HLA typing methods for Sanger and NGS platforms.

    GenDx is located in the Netherlands and the US, it is part of the Eurobio Scientific Group since October 2022.
10.2022

01. 2022

Acquisition of Biomedical Diagnostics, a distributor of in-vitro diagnostic equipment

  • Biomedical Diagnostics (BMD) is active in distribution, sales and marketing of high level in vitro diagnostics products and instrumentation in the Benelux.
    It sells specialized products in niche markets, with scientific and technical skills of its staff as added value for its customers.
    BMD has a professional team of people located in Belgium and in The Netherlands to achieve this goal.

    BMD specializes in Auto-Immunity, Microbiology for infectious diseases, quality controls and monitoring of biotherapies.

    BMD is located in Belgium from which it also serves The Netherlands, and is part of the Eurobio Scientific Group since June 2022.
01. 2022

2021

Acquisition of a minority stake in Usense, a start-up specialising in urine tests

  • Acquisition of a minority stake in Usense, a start-up specialising in urine tests
2021

2020

Acquisition of TECOmedical AG, a supplier of specialised in-vitro tests

  • The Swiss-based TECOmedical Group is a leading provider of in-vitro speciality test systems in the areas of medical and veterinary diagnostic, biosafety and environmental testing. In addition it develops and evaluates new test systems in collaboration with opinion leaders or as service to pharma, CRO and research organisations.

    TECOmedical is located in Switzerland and Germany. It also covers Austria, and is part of the Eurobio Scientific Group since July 2020.
2020

2019

   

Acquisition of Pathway & Personal Diagnostic

  • Eurobio Scientific UK (previously Pathway Diagnostics Ltd) has been supplying haemostasis, immunology, quality control materials and infectious disease products as a distributor and manufacturer to the UK and Ireland IVD, research, and industrial markets since 1998. The Company also operates its independent PathQAS Quality Assurance schemes for Coagulation, Allergy, Autoimmune serology, Calprotectin and Prekallikrein Activator assays.

    ‍

    The Eurobio Scientific Group also markets a range of self-tests on the British market through another subsidiary, Personal Diagnostics, which specializes in online sales (www.eurobio-scientific.co.uk/).

    ‍

    Eurobio Scientific UK and Personal Diagnostics are both located in the southwest of London, and are part of the Eurobio Scientific Group since july 2019.

2019

2018

  • Eurobio Scientific acquired Dendritics, a company specialising in the manufacturing of antibodies
2018

2017

Merger with listed company Diaxonhit (reverse takeover)

Acquired GenBio (USA)

  • Formed in 1994, GenBio is an experienced, fully integrated medical diagnostic company focused on infectious disease and autoimmune disease diagnostics. The company develops, manufactures and markets extensive lines of infectious disease and autoimmunity serology products under U.S. FDA and ISO 13485 standards. These products are intended to identify the presence of antibodies to specific infectious and autoimmune diseases.

    Genbio is located north of San Diego, California, and is part of the Eurobio Scientific Group since july 2017.
2017

2017

  • Inception of Eurobio Scientific Group
2017

2010

  • Eurobio Laboratoires acquisition by J-M. Carle and Denis Fortier
2010

1962

Eurobio

  • Creation of Laboratoires Eurobio by Pierre Réveilleau
 
1962

Search

en_GB
en_GB fr_FR it_IT es_ES de_DE
Scroll to Top